[{"id":"lancet-oncology","kind":"journal","name":"The Lancet Oncology","route":"/journals/lancet-oncology/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/journals.ts","type":"changed","fields":[{"field":"tldr","before":"\"The leading specialist cancer journal for clinical trials. Publishes phase 2 and 3 trials, long-term follow-up, quality-of-life analyses and global-oncology policy Commissions.\"","after":"\"The Lancet Oncology is the leading specialist cancer journal for clinical trials. It publishes phase 2 and 3 trials, long-term follow-up, quality-of-life analyses and global-oncology policy Commissions.\""},{"field":"summary","before":"\"Monthly plus online-first. Publishes a large share of randomised oncology trials that do not go to NEJM, with particular strength in radiotherapy, surgery, supportive care and health-system studies (IBIS-I tamoxifen ...","after":"\"The Lancet Oncology appears monthly plus online-first and publishes a large share of randomised oncology trials that do not go to NEJM, with particular strength in radiotherapy, surgery, supportive care and health-sy..."}]},{"id":"lancet-oncology","kind":"journal","name":"The Lancet Oncology","route":"/journals/lancet-oncology/","commit":"3d932e7abd","date":"2026-09-09","author":"Jude Gomila","message":"Journals: records for every venue cited by key papers","file":"src/data/journals.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"aka"},{"field":"matchNames"},{"field":"publisher"},{"field":"url"},{"field":"issn"},{"field":"scope"},{"field":"access"},{"field":"founded"},{"field":"impactFactor"},{"field":"wikipedia"},{"field":"tldr"},{"field":"summary"},{"field":"links"},{"field":"related"}]}]